Introduction
============

Echinococcosis, also termed cystic echinococcosis, is a type of zoonosis caused by the larval stages of *Echinococcus granulosus (E. granulosus)*. This disease is endemic and widespread throughout the world ([@b1-br-0-0-827]--[@b4-br-0-0-827]). In China, it is mainly endemic in large pastoral areas of northwestern regions, such as Xinjiang, Gansu, Qinghai, and Inner Mongolia, as well as in southwestern areas, such as Sichuan and Tibet ([@b5-br-0-0-827]). The life cycle of this cestode involves dogs, wolves and other canids as definitive hosts, and intermediate hosts are usually sheep, cattle, goats and pigs. However, humans may become accidental intermediate hosts when food and water sources are contaminated by the eggs of *E. granulosus*. Echinococcosis causes significant harm to human health and hampers the development of local animal husbandry. At present, many actions have been taken to cure this disease; however, few are sufficiently effective to cure it completely. Surgery in combination with chemotherapy has been identified as most efficacious and has become the first choice of therapy. However, this therapeutic strategy inevitably entails surgical risk and requires considerable labour, material and financial resources ([@b6-br-0-0-827]). An earlier diagnosis correlates to more effective surgery and chemotherapy. Therefore, early diagnosis is of great importance to the treatment of echinococcosis. However, early diagnosis continues to be an obstacle for doctors, as it is difficult to confirm the larvae using imaging diagnosis ([@b7-br-0-0-827]--[@b10-br-0-0-827]). Immunological methods are more promising, however, to the best of our knowledge, no studies regarding the early diagnosis of the *E. granulosus* infection have been performed. Therefore, there is an urgent requirement to develop effective preventative and treatment strategies.

A study by Lightowlers *et al* ([@b11-br-0-0-827]) revealed that the Eg95 recombinant antigen induced a 95--100% protective immune effect against oncospheres in sheep. Thus, immune prevention may be an effective measure that could be taken to prevent cystic echinococcosis. Strohmaier *et al* ([@b12-br-0-0-827]) identified the immunogenic amino acid sites of the foot and mouth disease virus and thereby designed novel epitope vaccines. With the rapid development of molecular biology and immunology, epitope vaccines have become the focus of research on molecular vaccines ([@b13-br-0-0-827]). To prevent infection by *Echinococcus multilocularis (E. multilocularis)*, Kouguchi *et al* ([@b14-br-0-0-827]) developed the Emy162 recombinant antigen, which induced a 74.3% protective rate in rats against *E. multilocularis*. In addition, Katoh *et al* ([@b15-br-0-0-827]) developed a vaccine based on the Em95 protein, and the protective efficiency of the vaccine was 78.5--82.9%. These results suggest that the prevention of echinococcosis using a molecular vaccine is feasible.

Antigen 5 (Ag5) is one of the dominant antigens of *E. granulosus* cyst fluids. It is a dimeric protein composed of 22- and 38-kDa subunits linked by a disulphide bridge, with the two subunits bearing an N-glycan modification ([@b16-br-0-0-827],[@b17-br-0-0-827]). The 38-kDa subunit is closely associated with serine proteases of the trypsin family ([@b16-br-0-0-827]). It has been confirmed that Ag5 is expressed in all stages of the life cycle of *E. granulosus* ([@b18-br-0-0-827]). Ag5 is strongly expressed in the protoscolex tegument, the embryonic membrane of eggs, and the surface of oncospheres; it is also expressed weakly in the adult tegument. As a result of this, the present study hypothesized that Ag5 may have diagnostic value and serve as a candidate antigen for a vaccine against cystic echinococcosis. To the best of our knowledge, recent studies regarding Ag5 have primarily focused on the diagnostic evaluation of cystic echinococcosis ([@b16-br-0-0-827]--[@b19-br-0-0-827]). Yarzabal *et al* ([@b20-br-0-0-827]) demonstrated the occurrence of cross-reactions in ELISA detection between Ag5 and other parasites, such as *E. multilocularis* and certain other helminthes. This result revealed the low specificity of this protein, thus Ag5 could not be widely applied in clinical diagnosis. However, whether Ag5 may be a candidate vaccine for cystic echinococcosis remains unclear.

In the current study, computer technology and online molecular biology software were used to predict various characteristics of Ag5, particularly the B and T cell epitopes, to analyze its immunogenicity and lay the theoretical foundation for further investigation of epitope vaccines against cystic echinococcosis.

Materials and methods
=====================

### Amino acid sequence of Ag5

The nucleotide sequence of Ag5 was selected from GenBank (NIH, Bethesda, MD, USA; GenBank no. JF970202). The amino acid sequence of Ag5 was predicted by DNAman software (LynnonBiosoft, San Ramon, CA, USA).

### Prediction of the Ag5 protein secondary structure

The secondary structure of Ag5 protein was predicted using the Self-Optimized Prediction method With Alignment (SOPMA) Server (<https://npsa-prabi.ibcp.fr/cgibin/npsa_automat.pl?page=npsa_sopma.html>) ([@b21-br-0-0-827]). The sequence of Ag5 protein was input, then four conformational states were predicted. The transmembrane structure of Ag5 protein was predicted by TMHMM Server v. 2.0 (<http://www.cbs.dtu.dk/services/TMHMM/>) ([@b22-br-0-0-827]). The sequence of Ag5 protein was input, and three regions, including inside, transmembrane and outside regions, were analyzed.

### Prediction of the Ag5 protein tertiary structure

The tertiary structure of Ag5 protein was predicted using the online prediction server 3DLigandSite (<http://www.sbg.bio.ic.ac.uk>) ([@b23-br-0-0-827]). To improve the accuracy of the prediction, the tertiary structure was also predicted using an additional online software application, Center for Biological Sequence Analysis (CBS) Prediction Servers (<http://www.cbs.dtu.dk/services>) ([@b24-br-0-0-827]). The 3DLigandSite software used homology modelling to predict the tertiary structure, as did the CBS Prediction Servers. When the sequence of Ag5 was input, a high homology model was output.

### Prediction of Ag5 protein epitopes

#### Prediction of the Ag5 protein B cell epitopes

The B cell epitopes of the Ag5 protein were predicted using the online prediction software Immune Epitope Database (IEDB; <http://tools.immuneepitope.org/bcell/>) ([@b25-br-0-0-827]). The sequence of Ag5 protein was input, and then the thresholds were all set to 1.0. The other parameters were not changed.

#### Prediction of the Ag5 protein T cell epitopes

Major histocompatibility complex (MHC)-I human leukocyte antigen (HLA)-A\*0201-restricted T cell epitopes were predicted by the online prediction software BioInformatics and Molecular Analysis Section (BIMAS; <http://www-bimas.cit.nih.gov/molbio/hla_bind/>) ([@b26-br-0-0-827]) together with SYFPEITHI (<http://www.syfpeithi.de/bin/MHCServer.dll/EpitopePrediction.htm>) ([@b27-br-0-0-827]). The amino acid sequence of Ag5 protein was input, the HLA molecule was set as HLA-A\*0201, and the nonamers were set to 9. The remaining parameters were not altered.

#### Prediction of various physicochemical properties of the Ag5 protein

Various physicochemical properties of the Ag5 protein were predicted by the online prediction software ProtParam (<http://web.expasy.org/protparam/>) ([@b28-br-0-0-827]). The sequence of Ag5 protein was input and five properties, including molecular weight, theoretical isoelectric point (pI), the instability index, the aliphatic index and the grand average of hydropathicity (GRAVY) were analyzed.

Results
=======

### Amino acid sequence encoded by the Ag5 gene

The open reading frame of Ag5 is 1,455 bp in length and encodes 484 amino acids, as predicted by DNAman software ([Fig. 1](#f1-br-0-0-827){ref-type="fig"}).

### Secondary structure of the Ag5 protein

To analyze the immunogenicity of the Ag5 protein, its secondary structure was predicted using SOPMA Server, and the results revealed that α-helixes, β-turns, random coils and extended strands accounted for 23.35, 10.95, 41.32, and 24.38% of the secondary structure, respectively. The predicted secondary structure results for the Ag5 protein are displayed in [Fig. 2](#f2-br-0-0-827){ref-type="fig"}. The high proportion of random coils and extended strands in the structure of Ag5 protein suggest that the protein is likely to form antigenic epitopes.

The transmembrane structure of Ag5 protein was predicted using the online CBS prediction software TMHMM Server version 2.0. The inside, transmembrane and outside regions of Ag5 were located at positions 1--6, 7--26 and 27--484, respectively. The results are displayed in [Fig. 3](#f3-br-0-0-827){ref-type="fig"}.

### Tertiary structure of the Ag5 protein

The tertiary structure of the Ag5 protein was predicted using the online prediction server 3DLigandSite and compared with the structure from the CBS Prediction Servers. The results are displayed in [Fig. 4](#f4-br-0-0-827){ref-type="fig"}.

### Epitopes of the Ag5 protein

### B cell epitopes of the Ag5 protein

B cell epitopes of Ag5 protein were predicted using the online prediction software IEDB ([Fig. 5](#f5-br-0-0-827){ref-type="fig"}). High-scoring regions of β-turn were located at positions 26--30, 36--50, 64--80, 87--102, 117--131, 142--168, 177--202, 210--216, 248--267, 327--346, 355--396, 403--416, and 422--473, and the accessible surface areas were located at positions 91--96, 116--121, 128--138, 146--183, 195--200, 284--293, 340--347, 359--373, 385--395, 412--417, and 460--468. The flexible regions were 27--40, 46--50, 68--77, 90--104, 114--123, 127--182, 190--199, 214--225, 249--253, 264--269, 278--295, 310--314, 323--333, 339--349, 358--373, 387--397, 403--408, 413--417, 423--428, 423--428, 432--447, and 455--473, and the possible antigenic regions proved to be 5--35, 57--63, 73--83, 85--92, 94--112, 121--128, 181--192, 201--209, 224--249, 252--262, 270--284, 293--325, 333--341, 348--355, 375--380, 398--404, 406--412, 418--424, 427--432, 448--454, 459--465, and 469--479. Areas that had high hydrophilicity were located at positions 26--40, 45--50, 64--67, 70--96, 100--105, 113--183, 191--198, 210--228, 249--253, 263--268, 277--296, 310--315, 326--351, 357--371, 389--397, 403--436, 440--447, 454--464, and 471--474, and the linear epitopes were demonstrated to be 29--39, 70--76, 90--99, 114--121, 128--136, 146--182, 193--201, 211--216, 260--267, 280--294, 308--314, 326--349, 357--372, 387--396, 402--436, 443--447, and 454--462.

A combination of the results predicted by the different parameters indicated that the B cell epitopes were located at positions 27--39, 70--80, 117--130, 146--168, 250--262, 284--293, 339--349, 359--371, 403--412, and 454--462.

### T cell epitopes of the Ag5 protein

To increase the accuracy of the prediction, T cell epitopes were predicted using the online prediction software BIMAS together with SYFPEITHI. There were 20 high-scoring regions, and the results are presented in [Table I](#tI-br-0-0-827){ref-type="table"}. These two software programs use different predicting systems. The BIMAS software resulted in high scores ranging from 3.932 to 1,737.776; however, the high scores predicted by the SYFPEITHI software ranged between 19 and 27. These high-scoring regions had strong potential of forming epitopes regardless of the difference.

Comparing the results predicted by the two online programs, seven high-scoring T cell epitopes were found to be located at positions 52--60, 57--65, 182--190, 231--239, 273--281, 318--326 and 467--475.

### Physicochemical properties of the Ag5 protein

The molecular weight of Ag5 is 54,874.8 Da, and its theoretical pI is 6.36. The instability index is computed to be 55.78, classifying the protein as unstable. The aliphatic index and GRAVY were found to be 69.32 and −0.525, respectively.

Discussion
==========

In China, cystic echinococcosis is a public health problem requiring a prompt solution. Furthermore, the infection region is gradually expanding ([@b29-br-0-0-827]). Currently, surgery in combination with chemotherapy is the first choice as a treatment strategy for cystic echinococcosis; however, it is not completely effective and the disease recurs. Immune prevention may be an effective measure to prevent the epidemic of cystic echinococcosis. Thus, developing a novel and effective vaccine is considered to be important.

It has been confirmed that Ag5 is expressed in all stages of the life cycle of *E. granulosus* ([@b18-br-0-0-827]), such as the tegument of the protoscolex, the embryonic membrane of eggs, the surface of oncospheres and adults. Thus, Ag5 presents as a promising vaccine for cystic echinococcosis.

Obtaining information regarding antigen epitopes will facilitate the development of epitope vaccines. Previously, epitope prediction was performed using a single parameter and its accuracy was limited. Now, as a result of the development of bioinformatics, the prediction of epitopes is accurate and simple. Making predictions using a multi-parameter and multi-method analysis improves the accuracy of epitope prediction greatly. In a study by Li *et al* ([@b30-br-0-0-827]), HLA-A\*0201, HLA-A\*1101 and HLA-A\*2401 cytotoxic T lymphocyte restricted epitopes of platelet membrane glycoprotein IIb/IIIa (GP IIb/IIIa) antibody of human and mice were predicted using SYFPEITHI, RANKPEP, BIMAS, SVMHC, PREDEP, MHCPRED and PROPRED software, and the T cell epitopes of GP IIb/IIIa antibody were predicted. In a different study conducted by Shen *et al* ([@b31-br-0-0-827]), the secondary structure and surface characteristics of the follicle stimulating hormone receptor (FSHR) extracellular domain were analyzed using DNAStar Protean software, and B cell epitope prediction was conducted using alternative online software. The possible antigenic epitopes of the FSHR extracellular domain were predicted, the peptides of the epitopes were synthesized and the immunogenicity of these peptides was determined.

In the current study, the transmembrane structure of Ag5 was predicted and inside, transmembrane and outside regions were identified. The transmembrane region was stable and it could not alter or form epitopes easily. The outside region, which constituted the majority of the structure, was located at position 27--484. The flexible areas usually appeared here and this region could potentially form epitopes.

The secondary structure of the Ag5 protein was predicted, as it was closely associated with antigenic features. The α-helixes and extended strands are regular structures in the secondary structure of the Ag5 protein. They are not deformed readily, as hydrogen bonds maintain the stability of their structure. However, ligand binding is difficult as the α-helixes and extended strands are located inside the protein. By contrast, random coils and β-turns are located at the surface of Ag5, and they are suitable for ligand binding. Therefore, it is possible for these to form epitopes. As predicted by the SOPMA Server software, the proportion of α-helixes was 23.35% and that of the extended strands was 24.38%. Thus, it was inferred from the results that the Ag5 protein has good stability. Furthermore, random coils and β-turns, which represent potential epitope regions, account for 41.32 and 10.95% of the protein, respectively.

The tertiary structure is based on the secondary structure of the protein, and it is a three-dimensional globular structure composed of further coiling and folding of secondary structure elements, such as α-helixes, β-turns, random coils and extended strands. The tertiary structure clarified that the random coils and β-turns are located at the surface of Ag5, and are suitable for ligand binding. These regions form epitopes easily. Therefore, the tertiary structure prediction was a necessary supplement to the prediction of Ag5 antigenic epitopes.

To improve the accuracy of the B cell epitope prediction, a multi-parameter analysis was utilized. The β-turn parameter prediction indicated that the β-turn is one of the normal types in the secondary structure of the protein. Hydrogen bonds alter the direction of the peptide chains, similarly to a U-model structure. Epitopes are able to easily form in these regions. Accessibility reflects the possibility of being found on the surface; the higher the accessibility, the more likely epitopes are to form. The flexibility parameter prediction demonstrates the ability of the protein to bend and fold. With a greater flexibility, the polypeptide skeleton of a protein has a strong capacity to bend and fold, thus promoting the formation of a secondary structure. The antigenic propensity demonstrated the immunogenic regions of the Ag5 protein. Those regions with high antigenic propensity are closely associated with the epitopes of the protein. The hydrophilicity parameter prediction explains the position of hydrophilic residues in the amino acid sequence of the protein. The hydrophilic residues are located on the surface of the protein and are suitable for ligand binding. The dominant epitopes are more likely to be located in regions with a high hydrophilicity. In combination with these parameters, the B cell epitopes of the Ag5 protein were predicted using IEDB software. Potential epitopes were revealed and were located at positions 27--39, 70--80, 117--130, 146--168, 250--262, 284--293, 339--349, 359--371, 403--412 and 454--462.

In the Chinese population, HLA-A\*0201 is the most common HLA-I molecule ([@b32-br-0-0-827]). The accuracy of the MHC-I epitope prediction in the prediction of the T cell epitopes is declared to be ≤90%. To increase the accuracy of the prediction, the T cell epitopes were predicted using BIMAS and SYFPEITHI software. Taken together, the T cell epitopes of the Ag5 protein were found to be located at positions 52--60, 57--65, 182--190, 231--239, 273--281, 318--326, and 467--475.

The aim of the present study was to obtain the bioinformatic characteristics of the Ag5 protein and analyze its immunogenicity. The results of the secondary structure prediction demonstrated that there are potential epitopes in the protein. The B cell epitopes were found to be located at positions 27--39, 70--80, 117--130, 146--168, 250--262, 284--293, 339--349, 359--371, 403--412, and 454--462; whereas the T cell epitopes were found to be located at positions 52--60, 57--65, 182--190, 231--239, 273--281, 318--326, and 467--475. These regions possess great potential for forming epitopes.

In conclusion, the current study predicts significant biological data for *E. granulosus* Ag5 to provide a theoretical basis for investigating its antigenicity and provides a theoretical foundation for epitope vaccine development for cystic echinococcosis.
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###### 

Major histocompatibility complex-Inonamer T cell epitope using BIMAS and SYFPEITHI.

       BIMAS software   SYFPEITHI software                                
  ---- ---------------- -------------------- ---------- ----- ----------- ----
  1    52               LMFNRSLFV            1737.776   395   SLNEIRVSI   27
  2    467              WLYNSVGSV            306.118    467   WLYNSVGSV   27
  3    318              ALLRLETPV            257.342    318   ALLRLETPV   25
  4    476              IQWINRYAV            99.501     18    AALGLELTL   24
  5    231              TLITPRWVL            65.689     273   LLVRAGDTV   24
  6    273              LLVRAGDTV            57.937     231   TLITPRWVL   23
  7    9                IVFVCLFAT            54.713     16    ATAALGLEL   22
  8    395              SLNEIRVSI            42.774     52    LMFNRSLFV   22
  9    237              WVLTAAHCL            31.814     57    SLFVYRENI   22
  10   299              LVVIHPDWV            27.882     182   RLPYSLKIL   22
  11   182              RLPYSLKIL            20.145     213   NASEGLTRL   22
  12   57               SLFVYRENI            18.915     50    ATLMFNRSL   21
  13   8                WIVFVCLFA            17.282     226   IICGGTLIT   21
  14   272              FLLVRAGDT            16.488     6     PLWIVFVCL   20
  15   442              NEEDGRWYV            14.638     24    LTLDPDELV   20
  16   24               LTLDPDELV            12.207     225   NIICGGTLI   20
  17   471              SVGSVIQWI            11.548     247   PIFGSSNAL   20
  18   11               FVCLFATAA            7.599      327   NIESDGAGV   20
  19   6                PLWIVFVCL            7.411      330   SDGAGVACV   20
  20   230              GTLITPRWV            3.932      189   ILGGKSAKS   19

BIMAS, BioInformatics and Molecular Analysis Section.
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